|
Pricing
Are Global Markets Free-Riding on the US?
“Global free-riding” is frequently raised in discussions about drug prices and the cost of drug development. The global free-riding problem is the perception that the U.S. is subsidizing drugs for the rest of the world due to its high drug prices compared to other countries in the world, but this is a complicated case to make, and the issue goes far beyond just getting a free ride ...Read more
learn more about how to leverage Data and Analytics to enhance Copay Program Performance with this White Paper and Case Study:  Read more
Product Launch
Launch Blueprint: Four Steps to Success
As new drug launches proliferate in the hotly contested specialty therapeutic space, companies are finding that success is often pre-determined by actions that take place very early in the development and commercialization cycle. Done right, these actions can help a new medicine outperform on the timelines to market launch. Keryx Biopharmaceuticals shares with us its four steps to successful launch
...Read more
The Patient Experience Project is a patient-centric communications agency that collaborates with the foremost disease experts—the patients themselves. We co-create authentic programs and engaging content for patients, caregivers, and healthcare professionals. Our experience has shown us that co-creation doesn’t just deliver more effective marketing initiatives; it fundamentally changes how it feels to do our jobs—and it feels good.  Learn more
R&D
New Financial Models for Biomedical Innovation
The ongoing battle over drug reimbursement and pricing has raised questions about whether the pharmaceutical industry can continue to rely on high U.S. revenues to fund biopharmaceutical R&D. Payers and insurers have become more aggressive in demanding clear evidence of value for high-priced medicines and are rejecting old models for coverage and reimbursement ...Read more
Leadership
Pharm Exec’s 2015 Emerging Pharma Leaders — Nominate Now!
Pharm Exec is looking for the fresh faces of pharma leadership, and we'd like your input! Tell us who you think should be included as one of Pharmaceutical Executive's 2015 Emerging Pharma Leaders. Read more for details of how to nominate a colleague — or yourself. The deadline for this year’s entries is April 15
...Read more
Social Media & Marketing
Memes: How Can Pharma Use Them?
Memes are tough to control no matter what industry you're in. And in the highly regulated, to put it mildly, environment of pharmaceutical marketing, it's safe to say that PLS companies are very limited at creating, using, and controlling these rapidly moving and dynamic idea vehicles ...Read more
|
